Ultrasound features as predictive markers of BRAFV600E mutation in thyroid cancer: a systematic review and meta-analysis

被引:0
|
作者
Liu, Rongwei [1 ,2 ]
Li, Haiyuan [1 ]
Bai, Xiumei [1 ]
Yang, Hong [1 ]
He, Yun [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Med Ultrasound, 6 Shuangyong Rd, Nanning 530021, Peoples R China
[2] Gannan Med Univ, Affiliated Hosp 1, Dept Med Ultrasound, Ganzhou, Peoples R China
关键词
Thyroid cancer; ultrasound features; BRAFV600E; meta-analysis; BRAF MUTATION; CARCINOMA;
D O I
10.21037/gs-24-134
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Conflicting evidence exists on the predictive value of ultrasound characteristics for BRAFV600E gene expression in thyroid cancer. This study aimed to determine the predictive value of ultrasound features for BRAFV600E gene expression status in thyroid cancer. Methods: A systematic review of studies published before December 31, 2023, was conducted in the PubMed, Web of Science, and Cochrane Library databases. Studies evaluating the ultrasonographic features for predicting BRAFV600E gene mutations in thyroid cancer were included. The relevant data were extracted, and the quality of eligible studies was independently assessed by two reviewers. Statistical analysis was performed using RevMan 5.4 and Stata 12.0 software. Results: The meta-analysis included 13 studies involving a total of 2,250 thyroid cancer patients. Ultrasound features significantly associated with BRAFV600E gene expression status in thyroid cancer (P<0.05) comprised hypoechogenicity, absence of halo, irregular borders, and vertical orientation. Contrastingly, no significant differences were observed in solid composition, irregular shape, and microcalcifications (P>0.05). Among the seven ultrasound features, the ones with superior combined sensitivity for nodules were hypoechogenicity, solid composition, absence of halo, and irregular borders, with sensitivities of 0.93 [95% confidence interval (CI): 0.87-0.96], 0.93 (95% CI: 0.86-0.97), 0.83 (95% CI: 0.72-0.91), and 0.74 (95% CI: 0.64-0.83), respectively. Finally, the areas under the summary receiver operating characteristic (SROC) curve with the highest diagnostic performance were the absence of halo and hypoechogenicity, with area under the curve (AUC) of 0.84 (95% CI: 0.80-0.87) and 0.81 (95% CI: 0.77- 0.84), respectively. Conclusions: The expression status of the BRAFV600E gene in thyroid cancer correlates with nodules exhibiting hypoechogenicity, absence of halo, irregular borders, and taller-than-wide shape. Notably, the absence of a halo and hypoechogenicity were identified as the most predictive ultrasonic features. However, due to the limited sample size, there may be bias in the meta-analysis results, and more extensive research is necessary.
引用
收藏
页码:1243 / 1253
页数:14
相关论文
共 50 条
  • [1] BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis
    Li, Fei
    Chen, Guangqi
    Sheng, Chunjun
    Gusdon, Aaron M.
    Huang, Yueye
    Lv, Zhongwei
    Xu, Huixiong
    Xing, Mingzhao
    Qu, Shen
    ENDOCRINE-RELATED CANCER, 2015, 22 (02) : 159 - 168
  • [2] Predictive Value of BRAFV600E Mutation for Lymph Node Metastasis in Papillary Thyroid Cancer: A Meta-analysis
    Song, Jing-yong
    Sun, Shi-ran
    Dong, Fang
    Huang, Tao
    Wu, Bin
    Zhou, Jing
    CURRENT MEDICAL SCIENCE, 2018, 38 (05) : 785 - 797
  • [3] Predictive Value of BRAFV600E Mutation for Lymph Node Metastasis in Papillary Thyroid Cancer: A Meta-analysis
    Jing-yong Song
    Shi-ran Sun
    Fang Dong
    Tao Huang
    Bin Wu
    Jing Zhou
    Current Medical Science, 2018, 38 : 785 - 797
  • [4] Diagnostic value of fine needle aspiration BRAFV600E mutation analysis in papillary thyroid cancer: a systematic review and meta-analysis
    Fnais, Naif
    Soobiah, Charlene
    AL-Qahtani, Khalid
    Hamid, Jemila
    Perrier, Laure
    Straus, Sharon E.
    Tricco, Andrea C.
    HUMAN PATHOLOGY, 2015, 46 (10) : 1443 - 1454
  • [5] BRAFV600E mutation as a predictor of thyroid malignancy in indeterminate nodules: A systematic review and meta-analysis
    Jinih, M.
    Foley, N.
    Osho, O.
    Houlihan, L.
    Toor, A. A.
    Khan, J. Z.
    Achakzai, A. A.
    Redmond, H. P.
    EJSO, 2017, 43 (07): : 1219 - 1227
  • [6] BRAFV600E mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis
    Ma, Yu-jia
    Deng, Xiu-ling
    Li, Hui-qing
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2015, 35 (04) : 591 - 599
  • [7] BRAFV600E Mutation and Its Association with Clinicopathological Features of Papillary Thyroid Microcarcinoma: A Meta-Analysis
    马禹佳
    邓秀玲
    黎慧清
    Journal of Huazhong University of Science and Technology(medical Sciences), 2015, 35 (04) : 591 - 599
  • [8] Morphological features predictive for BRAFV600E mutation in papillary thyroid microcarcinomas
    Nechifor-Boila, Adela Corina
    Szasz, Emoke-Andrea
    Descotes, Francoise
    Berger, Nicole
    Zahan, Ancuta Elena
    Loghin, Andrada
    Ceteras, Delia Maria
    Borda, Angela
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2018, 59 (03) : 747 - 753
  • [9] BRAFV600E mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis
    Yu-jia Ma
    Xiu-ling Deng
    Hui-qing Li
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2015, 35 : 591 - 599
  • [10] The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?
    Nucera, Carmelo
    Lawler, Jack
    Hodin, Richard
    Parangi, Sareh
    ONCOTARGET, 2010, 1 (08) : 751 - 756